6-Dehydrogingerdione sensitizes human hepatoblastoma hep G2 cells to trail-induced apoptosis via reactive oxygen species-mediated increase of dr5

Journal of Agricultural and Food Chemistry

Volumn 58, Issue 9, 2010, Pages 5604-5611

  Chen, Chung Yi ^a   Tai, Cheng Jeng ^b   Cheng, Jiin Tsuey ^c   Zheng, Juan Juan ^d   Chen, Ying Zong ^a   Liu, Tsan Zon ^b   Yiin, Shuenn Jiun ^e   Chern, Chi Liang ^a  

^a FOOYIN UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^d Yuli Hospital   (Taiwan)

^e TAJEN UNIVERSITY   (Taiwan)

Author keywords

6 dehydrogingerdione; Apoptosis; DR5; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; DRUG DERIVATIVE; GINGERDIONE; GUAIACOL; REACTIVE OXYGEN METABOLITE; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

APOPTOSIS; ARTICLE; DRUG EFFECT; HEPATOBLASTOMA; HUMAN; LIVER TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ACETYLCYSTEINE; APOPTOSIS; CELL LINE, TUMOR; GUAIACOL; HEPATOBLASTOMA; HUMANS; LIVER NEOPLASMS; REACTIVE OXYGEN SPECIES; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

ZINGIBER OFFICINALE;

EID: 77952176583     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf904260b     Document Type: Article

References (33)

1. Sheridan, J. P.; Marsters, S. A.; Pitti, R. M.; Gurney, A.; Skubatch, M.; Baldwin, D.; Ramakrishnan, L.; Gray, C. L.; Baker, K.; Wood, W. I.; Goddard, A. D.; Godowski, P.; Ashkenazi, A. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors Science 1997, 277, 818-821
2. Yamanaka, T.; Shiraki, K.; Sugimoto, K.; Ito, T.; Fujikawa, K.; Ito, M.; Takase, K.; Moriyama, M.; Nakano, T.; Suzuki, A. Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines Hepatology 2000, 32, 482-490
3. Shankar, S.; Srivastava, R. Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications Drug Resist. Update 2004, 7, 139-156
4. Chen, J. J.; Chou, C. W.; Chang, Y. F.; Chen, C. C. Proteasome inhibitors enhance TRAIL-induced apoptosis through the intronic regulation of DR5: involvement of NF-kappa B and reactive oxygen species-mediated p53 activation J. Immunol. 2008, 180, 8030-8039
5. Kim, H.; Kim, E. H.; Eom, Y. H.; Kim, W. H.; Kwon, T. K.; Lee, S. J.; Choi, K. S. Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5 Cancer Res. 2006, 66, 1740-1750
6. Jung, E. M.; Lim, J. H.; Lee, T. J.; Park, J. W.; Choi, K. S.; Kwon, T. K. Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 (DR5) Carcinogenesis 2005, 26, 1905-1913
7. Horinaka, M.; Yoshida, T.; Shiraishi, T.; Nakata, S.; Wakada, M.; Saikai, T. The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand Mol. Cancer Ther. 2006, 5, 945-951
8. Ashkenazi, A.; Pai, R. C.; Fong, S.; Leung, S.; Lawrence, D. A.; Marsters, S. A.; Blackie, C.; Chang, L.; McMurtrey, A. E.; Hebert, A.; DeForge, L.; Koumenis, I. L.; Lewis, D.; Harris, L.; Bussiere, J.; Koeppen, H.; Shahrokh, Z.; Schwall, R. H. Safety and antitumor activity of recombinant soluble Apo2 ligand J. Clin. Invest. 1999, 104, 155-162
9. Lakin, N. D.; Jackson, S. P. Regulation of p53 in response to DNA damage Oncogene 1999, 18, 7644-7655
10. el-Deiry, W. S. Regulation of p53 downstream genes Semin. Cancer Biol. 1998, 8, 345-357
11. Meek, D. W. Mechanisms of switching on p53: a role for covalent modification? Oncogene 1999, 18, 7666-75
12. Shieh, S. Y.; Ikeda, M.; Taya, Y.; Prives, C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2 Cell 1997, 91, 325-34
13. Siliciano, J. D.; Canman, C. E.; Taya, Y.; Sakaguchi, K.; Appella, E.; Kastan, M. B. DNA damage induces phosphorylation of the amino terminus of p53 Genes Dev. 1997, 11, 3471-81
14. Mroz, R. M.; Holownia, A.; Chyczewska, E.; Chyczewski, L.; Braszko, J. J. p53 N-terminal Ser-15-P and Ser-20-P levels in squamous cell lung cancer after radio/chemotherapy Am. J. Respir. Cell Mol. Biol. 2004, 30, 564-568
15. Wu, G. S.; Burns, T. F.; McDonald, E. R., 3rd; Jiang, W.; Meng, R.; Krantz, I. D.; Kao, G.; Gan, D. D.; Zhou, J. Y.; Muschel, R.; Hamilton, S. R.; Spinner, N. B.; Markowitz, S.; Wu, G.; el-Deiry, W. S. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene Nat. Genet. 1997, 17, 141-143
16. Wen, J.; Ramadevi, N.; Nguyen, D.; Perkins, C.; Worthington, E.; Bhalla, K. Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells Blood 2000, 96, 3900-3906
17. Takimoto, R.; el Deiry, W. S. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site Oncogene 2000, 19, 1735-1743
18. Park, K. K.; Chun, K. S.; Lee, J. M.; Lee, S. S.; Surh, Y. J. Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice Cancer Lett. 1998, 129, 139-144
19. Manju, V.; Nalini, N. Chemopreventive efficacy of ginger, a naturally occurring anticarcinogen during the initiation, post-initiation stages of 1,2-dimethylhydrazine-induced colon cancer Clin. Chim. Acta 2005, 358, 60-67
20. Katsuya, E.; Emi, K.; Yoshiteru, O. Structures of antifungal diarylheptenones, gingerenones A, B, C and isogingerenone B, isolated from the rhizomes of Zingiber officinale Phytochemistry 1990, 29, 797-799
21. Schomber, T.; Kalberer, C. P.; Wodnar-Filipowicz, A.; Skoda, R. C. Gene silencing by lentivirus-mediated delivery of siRNA in human CD34+ cells Blood 2004, 103, 4511-4513
22. Chen, C. Y.; Liu, T. Z.; Chen, C. H.; Wu, C. C.; Cheng, J. T.; Yiin, S. J.; Shih, M. K.; Wu, M. J.; Chern, C. L. Isbootusilactone A-induced apoptosis in human hepatoma Hep G2 cells is mediated via increased NADPH oxidase-derived reactive oxygen species (ROS) production and the mitochondria-associated apoptotic mecahnisms Food Chem. Toxicol. 2007, 45, 1268-1276
23. Chen, C. H.; Chern, C. L.; Lin, C. C.; Lu, F. J.; Shih, M. K.; Hsieh, P. Y.; Liu, T. Z. Involovment of reactive oxygen species, but not mitochondrial permeability transition in the apoptotic induction of human SK-Hep-1 heptoma cells by shikonin Planta Med. 2003, 69, 1119-1124
24. Desagher, S.; Osen-Sand, A.; Nichols, A.; Eskes, R.; Montessuit, S.; Lauper, S.; Maundrell, K.; Antonsson, B.; Martinou, J. C. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis J. Cell Biol. 1999, 144, 891-901
25. Kruidering, M.; Evan, G. I. Caspase-8 in apoptosis: the beginning of "the end"? IUBMB Life 2000, 50, 85-90
26. Hsu, I. C.; Tokiwa, T.; Bennett, W.; Metcalf, R. A.; Welsh, J. A.; Sun, T.; Harris, C. C. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines Carcinogenesis 1993, 14, 987-992
27. Hengartner, M. O. The biochemistry of apoptosis Nature 2000, 407, 770-776
28. Li, H.; Zhu, H.; Xu, C. J.; Yuan, J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis Cell 1998, 94, 491-501
29. Luo, X.; Budihardjo, I.; Zou, H.; Slaughter, C.; Wang, X. Bid, a Bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors Cell 1998, 94, 481-490
30. Volkmann, X.; Fischer, U.; Bahr, M. J.; Ott, M.; Lehner, F.; Macfarlane, M.; Cohen, G. M.; Manns, M. P.; Schulze-Osthoff, K.; Bantel, H. Increased hepatotoxicity of tumor necrosis factor-related apoptosis-inducing ligand in diseased human liver Hepatology 2007, 46, 1498-1508
31. Pei, Z.; Chu, L.; Zou, W.; Zhang, Z.; Qiu, S.; Qi, R.; Gu, J.; Qian, C.; Liu, X. An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice Hepatology 2004, 39, 1371-1381
32. Kim, Y. S.; Schwabe, R. F.; Qian, T.; Lemasters, J. J.; Brenner, D. A. TRAIL-mediated apoptosis requires NF-κB inhibition and the mitochondrial permeability transition in human hepatoma cells Hepatology 2002, 36, 1498-1508
33. Hsin, Y. H.; Cheng, C. H.; Tzen, J. T.; Wu, M. J.; Shu, K. H.; Chen, H. C. Effect of aristolochic acid on intracellular calcium concentration and its links with apoptosis in renal tubular cells Apoptosis 2006, 11, 2167-2177